Linzagolix for treating moderate to severe symptoms of uterine fibroids

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 6.1 MB)

  Published:

  14 August 2024

• Final draft guidance committee papers (PDF 2.94 MB)

  Published:

  14 August 2024